Safety, Tolerability and Pharmacokinetics of 0.5% and 2.5% Cis-UCA Eye Drops in Adult Healthy Volunteers (Phase I)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01476332
Recruitment Status : Completed
First Posted : November 22, 2011
Last Update Posted : May 17, 2012
Kuopio University Hospital
Information provided by (Responsible Party):
Laurantis Pharma, Ltd.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2012
  Actual Study Completion Date : March 2012